New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Molecular Partners AG
MOLN
Shape
US Flag

NASDAQ

Unprofitable

Unprofitable

200M

Biotechnology

6.02USD
Shape0.31 ( 5.43%)
favorite-chart

Relative Strenght

21
favorite-chart

Volume Buzz

-74%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

53%

Quote Panel

Shape
Updated October 25, 2024
1W -9.14 % 1M 31.34 % 3M -2.99 % 1Y 62.11 %

Key Metrics

Shape
  • Market Cap

    199.83M


  • Shares Outstanding

    33.19M


  • Share in Float

    17.32M


  • Dividende

    0


  • Earning Date

    No Data


  • Price Target

    6.02


  • Average Volume

    24401


  • Beta

    0.614


  • Range

    3.32-12.7


  • Industry

    Biotechnology


  • Website

    https://www.molecularpartners.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

22.00x

P/S Ratio

1.11x

P/B Ratio

0.0

Debt/Equity

-733.0%

Net Margin

$-2.0

EPS

How MOLN compares to sector?

P/E Ratio

Relative Strength

Shape

MOLN

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$5M

Shape222%

2025-Revenue

$1.81

Shape-303%

2025-EPS

$3M

Shape78%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

Credit Suisse

downgrade

Previous: Not converted

2022-04-27

Now: Neutral

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

N/A

-0.42
vs -0.41

Q4.22

arrow
arrow

N/A

-0.56
vs -0.56

Q1.23

arrow
arrow

N/A

-0.49
vs 4.99

Q2.23

arrow
arrow

N/A

-0.55
vs -0.15

Q3.23

arrow
arrow

N/A

-0.40
vs -0.42

Q4.23

arrow
arrow

N/A

-0.68
vs -0.56

Q1.24

arrow
arrow

N/A

-0.39
vs -0.49

Q2.24

arrow
arrow

N/A

-0.51
vs -0.55

Q3.24

arrow
arrow

N/A

-0.53
vs -0.40

Q4.24

arrow
arrow

N/A

-0.55
vs -0.68

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

-34%

2.3M  vs 3.5M

Q4.22

arrow
arrow

+52%

2.7M  vs 1.8M

Q1.23

arrow
arrow

-98%

3M  vs 172.8M

Q2.23

arrow
arrow

-96%

415K  vs 11.7M

Q3.23

arrow
arrow

+9%

2.5M  vs 2.3M

Q4.23

arrow
arrow

-62%

1M  vs 2.7M

Q1.24

arrow
arrow

-10%

2.7M  vs 3M

Q2.24

arrow
arrow

+274%

1.6M  vs 415K

Q3.24

arrow
arrow

-86%

349.1K  vs 2.5M

Q4.24

arrow
arrow

-80%

201.6K  vs 1M

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

-5%

-0.05
vs -0.01

Q4.22

arrow
arrow

-8%

-0.08
vs -0.05

Q1.23

arrow
arrow

-7%

-0.07
vs -0.08

Q2.23

arrow
arrow

-8%

-0.08
vs -0.07

Q3.23

arrow
arrow

-6%

-0.06
vs -0.08

Q4.23

arrow
arrow

-11%

-0.11
vs -0.06

Q1.24

arrow
arrow

-7%

-0.07
vs -0.11

Q2.24

arrow
arrow

-10%

-0.10
vs -0.07

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

8

8
vs 9

-11%

Q4.22

arrow
arrow

9

9
vs 8

13%

Q1.23

arrow
arrow

6

6
vs 9

-33%

Q2.23

arrow
arrow

7

7
vs 6

17%

Q3.23

arrow
arrow

7

7
vs 7

NA

Q4.23

arrow
arrow

8

8
vs 7

14%

Q1.24

arrow
arrow

8

8
vs 8

NA

Q2.24

arrow
arrow

8

8
vs 8

NA

Earnings Growth

Latest News